Evidence mapPaperPMID 42582950Full record

ArticleAlzheimer's & dementia (New York, N. Y.)

ABCA7-80 moderates vascular stiffness-p-tau217 association in older African Americans.

Miray Budak, Kevin S Heffernan, Martina Ishaq, Victoria Paruzel, Demiana Abdalla, Soodeh Moallemian, Bernadette A Fausto, Fanny M Elahi, Mark A Gluck

Abstract read
In one paragraph

Article in Alzheimer's & dementia (New York, N. Y.). The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Miray BudakCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0000-0003-0552-8464
Kevin S HeffernanDepartment of Biobehavioral Sciences, Movement Science and Applied Physiology Teachers College, Columbia University New York New York USA.ORCID https://orcid.org/0000-0002-3499-1477
Martina IshaqCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0009-0000-5988-7425
Victoria ParuzelCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0009-0002-7858-5881
Demiana AbdallaCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0009-0000-5696-0236
Soodeh MoallemianCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0000-0002-6314-4074
Bernadette A FaustoDepartment of Health Science & Clinical Practice Thomas Jeffersonn University Philadelphia Pennsylvania USA.ORCID https://orcid.org/0000-0002-8412-1023
Fanny M ElahiDepartments of Neurology and Neuroscience Icahn School of Medicine at Mount Sinai New York New York USA.ORCID https://orcid.org/0000-0003-4663-4992
Mark A GluckCenter for Molecular & Behavioral Neuroscience Rutgers University-Newark Newark New Jersey USA.ORCID https://orcid.org/0000-0003-0538-2303

Funding

Risk Factors for Future Cognitive Decline and Alzheimers Disease in Older African AmericansR01AG053961 · RUTGERS THE STATE UNIV OF NJ NEWARK · 2025 to 2025
$1.4M
NIA NIH HHS R01 AG053961
6 · The paper itself

Abstract

Introduction: Compromised vascular health is increasingly linked to Alzheimer's disease (AD) risk. Estimated pulse wave velocity (ePWV), derived from age and blood pressure, and provides a practical, non-invasive index of vascular stiffness and overall vascular health. Older African Americans experience a disproportionate burden of vascular disease and AD. Genetic risk factors such as APOE ε4 and ABCA7-80 (rs115550680) further increase AD susceptibility. However, whether these genetic risks influence vascular stiffness and how that may interact with AD pathology remains unknown, especially in African Americans. Methods: A total of 143 older African Americans (mean age = 71.10 ± 6.83 years; 109 women) were included. We examined the effects of both ABCA7-80 and APOE ε4 genotypes on ePWV and plasma phosphorylated tau 217 (p-tau217). All regression models controlled for sex, education, pulse pressure, waist-to-hip ratio, global cognitive status, hypertension status, and APOE genotype (APOE genotype only used for ABCA7-80 regression models). Results: ABCA7-80 risk allele carriers exhibited higher ePWV ( Discussion: ABCA7-80 risk, but not APOE ε4, heightens susceptibility to the tau-related effects of compromised vascular health among older African Americans. These findings identify a genetically vulnerable subgroup in which vascular stiffness may disproportionately accelerate AD-related tau pathology and highlight vascular health as a modifiable target for reducing AD risk in African Americans.

Indexed as

ABCA7African ancestryAlzheimer's diseaseAPOEestimated pulse wave velocity (ePWV)phosphorylated tau 217 (p‐tau217)vascular healthvascular stiffness

Identifiers

PMID42582950
PMCPMC13459191

What Socratic holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.